200 related articles for article (PubMed ID: 37577745)
21. Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery.
Uchida Y; Maezawa Y; Uchida Y; Hiruta N; Shimoyama E; Kawai S
PLoS One; 2013; 8(2):e55188. PubMed ID: 23393566
[TBL] [Abstract][Full Text] [Related]
22. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P
Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248
[TBL] [Abstract][Full Text] [Related]
23. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs.
Holvoet P; Theilmeier G; Shivalkar B; Flameng W; Collen D
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):415-22. PubMed ID: 9514410
[TBL] [Abstract][Full Text] [Related]
24. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.
Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD
J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705
[TBL] [Abstract][Full Text] [Related]
25. Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study.
Langlois MR; Rietzschel ER; De Buyzere ML; De Bacquer D; Bekaert S; Blaton V; De Backer GG; Gillebert TC;
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1563-8. PubMed ID: 18511698
[TBL] [Abstract][Full Text] [Related]
26. Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis.
Puig N; Camps-Renom P; Solé A; Aguilera-Simón A; Jiménez-Xarrié E; Fernández-León A; Camacho M; Guasch-Jiménez M; Marin R; Martí-Fàbregas J; Martínez-Domeño A; Prats-Sánchez L; Casoni F; Pérez B; Jiménez-Altayó F; Sánchez-Quesada JL; Benitez S
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829998
[TBL] [Abstract][Full Text] [Related]
27. Oxidized Low-Density Lipoprotein (OxLDL)-Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let-7c Is Integral to the Effect.
Frostegård J; Zhang Y; Sun J; Yan K; Liu A
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27650878
[TBL] [Abstract][Full Text] [Related]
28. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
[TBL] [Abstract][Full Text] [Related]
30. Minimally Oxidized-LDL-Driven Alterations in the Level of Pathological Mediators and Biological Processes in Carotid Atherosclerosis.
Thankam FG; Rai T; Liu J; Tam J; Agrawal DK
Cardiol Cardiovasc Med; 2022; 6(2):137-156. PubMed ID: 35531433
[TBL] [Abstract][Full Text] [Related]
31. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig.
Post MJ; Borst C; Kuntz RE
Circulation; 1994 Jun; 89(6):2816-21. PubMed ID: 8205696
[TBL] [Abstract][Full Text] [Related]
32. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.
Markstad H; Edsfeldt A; Yao Mattison I; Bengtsson E; Singh P; Cavalera M; Asciutto G; Björkbacka H; Fredrikson GN; Dias N; Volkov P; Orho-Melander M; Nilsson J; Engström G; Gonçalves I
J Am Heart Assoc; 2019 Feb; 8(4):e009874. PubMed ID: 30744454
[TBL] [Abstract][Full Text] [Related]
33. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
[TBL] [Abstract][Full Text] [Related]
34. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
35. Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.
Al-Yafeai Z; Yurdagul A; Peretik JM; Alfaidi M; Murphy PA; Orr AW
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2601-2614. PubMed ID: 30354234
[TBL] [Abstract][Full Text] [Related]
36. Vulnerable plaque in a Swine model of carotid atherosclerosis.
Shi ZS; Feng L; He X; Ishii A; Goldstine J; Vinters HV; Viñuela F
AJNR Am J Neuroradiol; 2009 Mar; 30(3):469-72. PubMed ID: 19147719
[TBL] [Abstract][Full Text] [Related]
37. Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis.
Hutter R; Speidl WS; Valdiviezo C; Sauter B; Corti R; Fuster V; Badimon JJ
J Cardiovasc Transl Res; 2013 Aug; 6(4):558-69. PubMed ID: 23661177
[TBL] [Abstract][Full Text] [Related]
38. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
Torzewski M; Shaw PX; Han KR; Shortal B; Lackner KJ; Witztum JL; Palinski W; Tsimikas S
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
[TBL] [Abstract][Full Text] [Related]
39. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
40. Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
Willems S; van der Velden D; Quax PH; de Borst GJ; de Vries JP; Moll FL; Kuiper J; Toes RE; de Jager SC; de Kleijn DP; Hoefer IE; Pasterkamp G; Bot I
PLoS One; 2014; 9(2):e88984. PubMed ID: 24586471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
